Search for: "Lupin Pharmaceuticals Inc."
Results 1 - 20 of 25
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
20 Sep, 2007 10:05 pm
... 11, 2007), the District Court for the District of Maryland denied Baltimore-based Lupin Pharmaceuticals, Inc.'s (LPI) motion to dismiss an action against it and its parent, Mumbai ... had made the same arguments, unsuccessfully, in Aventis Pharma Deutschland GMBH v. Lupin Ltd., 403 F. Supp. 2d 484, 494 (E.D. Va ... which placed significance on LPI's countersignature as part of its agent-principal relationship with Lupin. But when a wholly-owned U.S. subsidiary of a foreign corporation exists to distribute ...
Maryland Intellectual Property Law Blog - http://www.marylandiplaw.com/
11 Sep, 2007 9:55 pm by Aaron Barkoff
... ,722, which covers ramipril, the active ingredient in Altace. Aventis owns the '722 patent and King Pharmaceuticals markets Altace under an exclusive license. Ramipril is a stereoisomer belonging to a family of compounds that includes 25 stereoisomers. ... inhibitors, or "ACE inhibitors," which are useful for treating high blood pressure. The prior art asserted by Lupin included structurally similar ACE inhibitors, including enalapril, as well as publications describing how to separate stereoisomers ...
Orange Book Blog - http://www.orangebookblog.com/
13 Feb, 2008 6:19 pm
... & Co. KGaA and Merz Pharma GmbH are German companies. Also according to the complaint, defendant Lupin Pharmaceuticals, Inc., a Virginia company based in Baltimore, MD, is the wholly-owned subsidiary and agent of Lupin Ltd., an ... its ANDA submission on December 14, 2007. Plaintiff is asserting infringement of the '703 patent, and is seeking to enjoin Lupin from marketing its generic formulation before expiration of the '703 patent. Interestingly, plaintiffs also filed a concurrent lawsuit in ...
Maryland Intellectual Property Law Blog - http://www.marylandiplaw.com/
9 Oct 9:11 am by Karen E. Keller
9/9: Warner Chilcott Company LLC v. Lupin Limited and Lupin Pharmaceuticals Inc. (patent infringement) 9/15: Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals ... . v. Gates Corporation (trademark infringement) 9/16: Fair Isaac Corporation v. Actimize Inc. and NICE Systems Ltd. (patent infringement) 9/17: US Philips Corporation v. Samsung Electronics Company Ltd. and Samsung Electronics America Inc. (patent infringement) 9/18: Research Foundation of State University of New York, New York ...
Delaware IP Law Blog - http://www.delawareiplaw.com/
13 Sep 9:31 pm by Patent Docs
... few interesting cases will be selected for periodic monitoring. Warner Chilcott C. LLC v. Lupin Limited et al. 1:09-cv-00673; filed September 9, ... District Court of Delaware • Plaintiff: Warner Chilcott Co. LLC • Defendants: Lupin Limited; Lupin Pharmaceuticals Inc. Infringement of U.S. Patent No. 5,552,394 ... Contraceptives with Less Breakthrough Bleeding and Sustained Efficacy," issued September 3, 1996) following a Paragraph IV certification as part of Lupin's filing of an ANDA to manufacture...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
28 Dec, 2008 2:24 pm by Donald Zuhn
... ," issued August 5, 1997) based on Abbott's manufacture and sale of its Humira ® (adalimumab, used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease and plaque psoriasis). View the complaint here.Eli Lilly and Company v. Lupin Pharmaceuticals, Inc. et al.3:08-cv-06261;...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
20 May 5:18 am
... global biotechnology innovation (BiotechBlog) Creative destruction in biotechnology (Biotech Blog) Africa pharmaceuticals trademark network? (Afro-IP) Brazil: Counterfeit and parallel importation of medicines ... pharmaceutical patent debate: wither drug safety?: Dr Reddy's post grant opposition against Pfizer's Champix patent (Spicy IP) Tanzania generic ... permitted commercial marketing or use PTE determinations: Ortho-McNeil Pharmaceutical et al v Lupin Pharmaceutical et al (FDA Law Blog) (FDA Law ...
IP Thinktank - http://duncanbucknell.com/blog
2 Jan, 2008 9:05 pm
... the number of patent infringement lawsuits involving life-sciences technologies (e.g., pharmaceuticals, biologics, and medical devices). In 2006, 21 plaintiffs filed 23 patent ... companies filing the most patent infringement lawsuits in Maryland in 2007 were Nutramax Laboratories, Inc., the Edgewood, MD, company that specializes in nutritional supplements, and Israel's Teva ... Directions, LLC et al Shire LLC v. Colony Pharmaceuticals, Inc. et al Wyeth v. Lupin Ltd. et al Contech Stormwater Solutions ...
Maryland Intellectual Property Law Blog - http://www.marylandiplaw.com/
17 Sep, 2007 2:00 pm by Stephen Albainy-Jenei
... The going is getting tougher. See Aventis Pharma Deutschland Gmbh and King Pharmaceuticals, Inc., v. Lupin, Ltd. (06-1530). In a patent infringement action concerning ... Lupin's filing of an Abbreviated New Drug Application (ANDA) for a generic version of ramipril infringed Aventis's U.S. Patent. No. 5,061,722 ... art still remaining "substantially free of other isomers." The district court held that Lupin failed to meet its burden of proof by clear and convincing evidence that a person of ordinary ...
Tags: Litigation, IP
Patent Baristas - http://www.patentbaristas.com/
25 Jul, 2008 2:11 am by Stephen Albainy-Jenei
... enzyme H+K+ATPase. Rabeprazole's sodium salt is the active ingredient in Aciphex, a pharmaceutical approved for the treatment of duodenal ulcers, heartburn, and associated disorders. Aciphex has over ... need not necessarily be explicit in the art. See Aventis Pharma Deutschland GmbH v. Lupin, Ltd., 499 F.3d 1293, 1301 (Fed. Cir. 2007). Rather "it ... identified, predictable solutions," 127 S. Ct. at 1742. In Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc., 520 F.3d 1358, 1364 (Fed. Cir. ...
Patent Baristas - http://www.patentbaristas.com/
24 Dec, 2008 9:04 am by Varun
After Lupin, Dr. Reddy's Laboratories has reported to settle all pending patent infringement lawsuits with Schering and Sepracor relating anti-allergic drug Clarinex (desloratadine). Under the settlement agreement, Dr. Reddy's will ... -months marketing exclusivity, and Clarinex Reditabs with six-months marketing co-exclusivity starting from 2012. Earlier, Schering and Sepracor have similar settlement agreements with generic manufacturers including Ranbaxy, Perrigo Co. and Watson Pharmaceuticals Inc.
Patent Circle - http://patentcircle.blogspot.com/
13 Jun, 2008 3:40 am
... dismisses Sanofi-Aventis' patent claims against generic Oxaliplatin maker Boryung Pharmaceutical Co: (GenericsWeb), Eloxatin (Oxaliplatin) - US: Sanofi-Aventis files patent infringement suit ... Storage: (IPRoo), TMO decides SIX IN THE CITY registrable: Home Box Office, Inc v Susan Stigwood Pty Ltd: (IPRoo), Employment qualifications for registered patent ... (IP Law360), (IP Law360), (IP Law360), (Hal Wegner), Quanta-fication of Lupin: (Hal Wegner), Green energy patents down in early 2008 finds study ...
IP Thinktank - http://duncanbucknell.com/blog
19 Dec, 2008 1:00 pm
... Cardizem (Diltiazem) - Antitrust, infringement claims split in Cardizem litigation between Biovail and Sun Pharmaceutical (Law360) Clarinex (Desloratadine) - US: Lupin settles Clarinex suit with Schering (Law360) (Patent Circle) Clarinex (Desloratadine) - US: ... (Law360) Levaquin (Levofloxacin) - Canada: Federal Court rejects inequitable conduct doctrine in Canada: Janssen-Ortho Inc v Apotex (International Law Office) Nexium (Esomeprazole) - US: AstraZeneca to add defendant, Cipla, and patent to ...
IP Thinktank - http://duncanbucknell.com/blog
15 Jul 5:15 am
... the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC ... of State University of New York, New York University and Galderma file patent infringement suit against Lupin following its ANDA to manufacture generic Oracea (Patent Docs) (GenericsWeb) Renagel (Sevelamer) - US: Genzyme files patent ...
IP Thinktank - http://duncanbucknell.com/blog
2 May, 2008 7:00 am
... ), India: SCC journal article 'Intellectual property rights and the challenges faced by the pharmaceutical industry': (Spicy IP), Poland: Trade marks for medicines: (Class 46), US: ... gift horse in the mouth - why would a company refuse a patent term extension?: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) - US: Apotex ... rules that myspace.co.uk domain does not need to be transferred to MySpace Inc, owners of myspace.com social networking site: (IPKat), Critics brand Phorm a regulatory ...
IP Thinktank - http://duncanbucknell.com/blog
28 Nov, 2008 12:49 pm
... of granting gene patents (Managing Intellectual Property) Europe: European Commission releases preliminary report on investigation into competition in the pharmaceutical industry (IP Think Tank) (Europa) Europe: EPO Enlarged Board of Appeal turns down Wisconsin Alumni Research ... against multiple generic-drug makers (Law360) Cymbalta (Duloxetine) - US: Eli Lilly adds Aurobindo Pharma and Lupin to long list of companies it has sued to block generic Cymbalta (Law360) Glivec (Imatinib) - India: IPAB ...
IP Thinktank - http://duncanbucknell.com/blog
18 Apr, 2008 2:00 am
... create another patent-free malaria drug: (Intellectual Property Watch), Argentina: Inconsistencies in the protection of scientific data - pharmaceuticals and agrochemicals: (International Law Office), India / Uganda: CIPLA, LDCs and parallel importation: interesting ... testing patent: (IP Law360), (Patent Docs), Abbott - Product-by-process; Scripps/Atlantic Thermoplastics conflict: Lupin v Abbott: (Hal Wegner), Acacia - Multidistrict litigation created for photo-printing patent suits brought by ...
IP Thinktank - http://duncanbucknell.com/blog
30 May, 2008 9:09 am
... ; Biotech - Products Altace (Ramipril) - US: King Pharmaceuticals files citizen petition relating to new patent on Altace, following Lupin's successful challenge against other ... patents unenforceable due to inequitable conduct: Aventis Pharma SA v Amphastar Pharmaceuticals: (Patent Docs), (IPBiz), Pantoloc (Pantoprazole) - Canada: Court dismisses motion to dismiss ... Court hands down ruling in trade mark case H-D Michigan Inc v MC Parts: (International Law Office), (Class 46) Europe Is Microsoft's ...
IP Thinktank - http://duncanbucknell.com/blog
5 Dec, 2008 1:00 pm
... [duncanbucknell.com] Highlights this week included: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight) (IAM) (Managing Intellectual Property) (Law360) (Patent Docs) (GenericsWeb) (IPKat) ... ; Barr, Mylan confirms challenge of Amrix patent (SmartBrief) (SmartBrief) (SmartBrief) (GenericsWeb) Antara (Fenofibrate) - US: Lupin files ANDA for generic Antara, challenging validity of Oscient's patent (Law360) (GenericsWeb) Boniva ( ...
IP Thinktank - http://duncanbucknell.com/blog
8 May 8:00 am
... after patent expired, Sun World has exclusive right to the subject matter: Sun Pacific Farming Co-op, Inc v Sun World Intern. (Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction ... - US: Pfizer files patent infringement suits against Sun Pharma, Lupin, Wockhardt, Cobalt, Actavis, Sandoz, Teva and Alphapharm to block generic Lyrica (Generic Pharmaceuticals and Patentology) (Patent Docs) Metrogel (Metronidazole) - US: Galderma drops patent suit against Tolmar over Metrogel ( ...
IP Thinktank - http://duncanbucknell.com/blog
        Next >
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck